Q&A: Dr. John Mazziotta on the future of UCLA’s medical school and health system

Earlier in his life, Dr. John C. Mazziotta thought about becoming an architect. With a keen eye for form and function, he would apply his skills to the construction of great buildings. Instead, he chose medicine. Now, after more than 30 years at UCLA — where he has been chair of the department of neurology, an associate vice chancellor and executive vice dean, and founding director of the Ahmanson-Lovelace Brain Mapping Center — that style of visual thinking will serve him well in his new roles as vice chancellor for UCLA Health Sciences, dean of the David Geffen School of Medicine at UCLA and CEO of UCLA Health. “There are many parallels between architecture and construction and what we do in medicine and the building of a large medical enterprise,” he said. “And, on a purely administrative level, it doesn’t hurt to have some interest in the subject when you are managing millions of square feet of space and renovating a giant building. Having some interest and experience about how these things work is helpful.” Mazziotta spoke with U Magazine editor David Greenwald about his new roles and his aspirations for the future of the medical school and health system. As vice chancellor, dean and CEO, you bridge the worlds of the health system and the medical school. How does each of these worlds inform the other? We have one health organization with two big pieces to it: the health system — the hospitals, the clinics, the doctors and n...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

BREAST cancer symptoms and signs develop when a few cells in this area start to divide uncontrollably. The most common cancer in women, there are also rare cases of the cancer developing in men. Watch out for these warning signs of breast cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
WARNING, GRAPHIC CONTENT: Sylvain Pharand, from Montreal, was told he had just six months to live when doctors told him a cyst in his left nostril was sinus and lymph node cancer.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Yu Tong, Tao Yu, Shiping Li, Fengyan Zhao, Junjie Ying, Yi Qu, Dezhi Mu
Source: Frontiers in Physiology - Category: Physiology Source Type: research
Might certain benign thyroid conditions influence the risk for developing thyroid cancer? This new study looks at the possible connection.Journal of Clinical Endocrinology &Metabolism
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
This report tracked pediatric cancer incidence by type and state.Morbidity &Mortality Weekly Report
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
  It takes a strong leader to admit when his time is up. Endologix CEO John McDermott is that type of leader, which he proved this week with the announcement that he will be stepping down as CEO of the struggling endovascular aneurysm repair (EVAR) company.     Endologix has had its fair share of hurdles over the past couple of years, but it seems like things might finally be looking up for the Irvine, CA-based company. In May, the company promoted John Onopchenko to the role of CEO. Prior to the promotion, Onopchenko was the company's chief operating officer, a p...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news
CONCLUSIONS: The result of this retrospective study allows us to say that the choice of the technique, in the presence of multiple risk factors, should be carefully assessed and discussed with the patient. A prospective study with a larger number of patients would allow a better definition of the risk determined by individual factors and the development of a score that could be used in practice to simplify the risk assessment KEY WORDS: Conversion to open surgery, Incisional hernia, Laparoscopy, Risk factors. PMID: 30007062 [PubMed - as supplied by publisher]
Source: Annali Italiani di Chirurgia - Category: Surgery Tags: Ann Ital Chir Source Type: research
The AHR represses nucleotide excision repair and apoptosis and contributes to UV-induced skin carcinogenesis, Published online: 16 July 2018; doi:10.1038/s41418-018-0160-1The AHR represses nucleotide excision repair and apoptosis and contributes to UV-induced skin carcinogenesis
Source: Cell Death and Differentiation - Category: Cytology Authors: Source Type: research
AbstractPurpose of reviewRecent studies demonstrate that normal human tissues accumulate substantial numbers of somatic mutations with aging, to levels comparable to their corresponding cancers. If mutations cause cancer, how do tissues avoid cancer when mutations are unavoidable?Recent findingsThe small intestines (SI) and colon accumulate similar numbers of replication errors, but SI adenocarcinoma is much rarer than colorectal cancer. Both the small and large intestines are subdivided into millions of small neighborhoods (crypts) that are maintained by small numbers of stem cells. To explain the SI cancer paradox, four ...
Source: Current Pathobiology Reports - Category: Laboratory Medicine Source Type: research
CONCLUSION: This is the first case to our knowledge describing both such lesions in one patient and the first case describing the use of 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (18F-DCFPyL)-PSMA PET/CT to detect IPAS. Furthermore we highlight the value of nuclear medicine diagnostic work up in complex cases. PMID: 30006647 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Academia | Allergy & Immunology | Biomedical Science | Brain | Brain Cancers | Breast Cancer | Breast Needle Aspiration | Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Cardiovascular | Childhood Cancer | Cholesterol | Clinical Trials | Computers | Education | Environmental Health | Food and Drug Administration (FDA) | Funding | Gastroschisis Repair | Genetics | Graduation | Health | Health Management | Heart | Hospitals | Jobs | Learning | Lessons | Lung Cancer | Melanoma | Men | Neurology | Neuroscience | Nurses | Nursing | Partnerships | Science | Skin Cancer | Strategic Planning | Students | Training | Universities & Medical Training